Agilent Technologies, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim Acquires Nerio The

Illumina is trying to reduce the uncertainty surrounding its leadership and direction by naming a new CEO. Jacob Thaysen, the current and president of Agilent Technologies ’ life sciences and appl

The US FDA’s approval of Ferring Pharmaceuticals ’ bladder cancer gene therapy Adstiladrin just two weeks after the company took home an approval for the pioneering microbiome therapeutic Rebyota res

Mirati Therapeutics, Inc. won accelerated approval from the US Food and Drug Administration for its KRAS G12C inhibitor Krazati (adagrasib) for second-line or later treatment of patients with non-sma